83 related articles for article (PubMed ID: 19421226)
1. Cytoplasmic mutated nucleophosmin (NPM1) in blast crisis of chronic myeloid leukaemia.
Piccaluga PP; Sabattini E; Bacci F; Agostinelli C; Righi S; Salmi F; Testoni N; Paolini S; Castagnetti F; Martinelli G; Falini B; Pileri SA
Leukemia; 2009 Jul; 23(7):1370-1. PubMed ID: 19421226
[No Abstract] [Full Text] [Related]
2. NPM1 mutations occur rarely or not at all in chronic myeloid leukaemia patients in chronic phase or blast crisis.
Watkins DB; Hughes TP; White DL; D'Andrea RJ
Leukemia; 2013 Feb; 27(2):489-90. PubMed ID: 22791379
[No Abstract] [Full Text] [Related]
3. Rapid flow cytometric detection of aberrant cytoplasmic localization of nucleophosmin (NPMc) indicating mutant NPM1 gene in acute myeloid leukemia.
Oelschlaegel U; Koch S; Mohr B; Schaich M; Falini B; Ehninger G; Thiede C
Leukemia; 2010 Oct; 24(10):1813-6. PubMed ID: 20724983
[No Abstract] [Full Text] [Related]
4. [Immunogenotypes and surface marker analysis in Ph1 positive chronic myelogenous leukemia in the blastic crisis].
Ohyashiki JH; Kawakubo K; Murakami T; Toyama K
Nihon Rinsho; 1992 Jun; 50(6):1262-6. PubMed ID: 1518143
[TBL] [Abstract][Full Text] [Related]
5. A comment on Megakaryocytic blast crisis as a presenting manifestation of chronic myeloid leukemia.
Lazarevic VLj
Leuk Res; 2010 Sep; 34(9):1253. PubMed ID: 20378169
[No Abstract] [Full Text] [Related]
6. JAK2V617F mutation in chronic myeloid leukemia predicts early disease progression.
Pahore ZA; Shamsi TS; Taj M; Farzana T; Ansari SH; Nadeem M; Ahmad M; Naz A
J Coll Physicians Surg Pak; 2011 Aug; 21(8):472-5. PubMed ID: 21798133
[TBL] [Abstract][Full Text] [Related]
7. T lymphoid/myeloid bilineal crisis in chronic myelogenous leukemia.
Akashi K; Mizuno S; Harada M; Kimura N; Kinjyo M; Shibuya T; Shimoda K; Takeshita M; Okamura S; Matsumoto I
Exp Hematol; 1993 Jun; 21(6):743-8. PubMed ID: 7684698
[TBL] [Abstract][Full Text] [Related]
8. Activity of a specific inhibitor of the BCR-ABL tyrosine kinase in the blast crisis of chronic myeloid leukemia and acute lymphoblastic leukemia with the Philadelphia chromosome.
Druker BJ; Sawyers CL; Kantarjian H; Resta DJ; Reese SF; Ford JM; Capdeville R; Talpaz M
N Engl J Med; 2001 Apr; 344(14):1038-42. PubMed ID: 11287973
[TBL] [Abstract][Full Text] [Related]
9. Immunophenotypic characteristics of blast crisis of chronic myeloid leukaemia: correlations with clinico-biological features and survival.
Urbano-Ispizua A; Cervantes F; Matutes E; Villamor N; Pujades A; Sierra J; Feliu E; Vives-Corrons JL; Montserrat E; Rozman C
Leukemia; 1993 Sep; 7(9):1349-54. PubMed ID: 8371586
[TBL] [Abstract][Full Text] [Related]
10. Extramedullary blast crisis in chronic myeloid leukemia--a case report.
Tondon R; Singh PA; Misra V; Singh M; Mohan S
Indian J Pathol Microbiol; 2005 Apr; 48(2):253-4. PubMed ID: 16758687
[TBL] [Abstract][Full Text] [Related]
11. bcr/abl mRNA in leukemic blasts of an unusual patient with acute lymphoblastic leukemia followed after 5-year remission by chronic myelogenous leukemia in blast crisis.
Fujie H; Tsuchiya S; Morita S; Itano M; Yambe T; Ohasi Y; Minegishi N; Minegishi M; Satou T; Konno T
Leukemia; 1994 Sep; 8(9):1592-5. PubMed ID: 8090037
[TBL] [Abstract][Full Text] [Related]
12. Role of immunophenotyping in characterisation of blast crisis of chronic myeloid leukemia--a study of 25 cases.
Padmanabhan V; Varma N; Dash S; Varma S
Indian J Pathol Microbiol; 1996 Jan; 39(1):13-7. PubMed ID: 8755126
[TBL] [Abstract][Full Text] [Related]
13. [Deletion (7)(p11p15): an infrequent abnormality in blast crisis in chronic myeloid leukemia].
Resino M; Ferro MT; García-Laraña J; García-Sagredo JM; Cabello P; López-Yarto A; San Román C
Sangre (Barc); 1994 Dec; 39(6):465-7. PubMed ID: 7855700
[TBL] [Abstract][Full Text] [Related]
14. [Blast crisis accompanied by severe DIC of Ph negative chronic myeloid leukemia showing t(9;16) and positive M-BCR/ABL rearrangement].
Fujiwara H; Takahashi N; Tada J; Higuchi T; Harada H; Mori H; Niikura H; Omine M; Fujita K
Rinsho Ketsueki; 1997 Aug; 38(8):663-68. PubMed ID: 9311272
[TBL] [Abstract][Full Text] [Related]
15. Promyelocytic blast crisis of chronic myelogenous leukemia during imatinib treatment.
Gozzetti A; Bocchia M; Calabrese S; Pirrotta MT; Crupi R; Raspadori D; Lauria F
Acta Haematol; 2007; 117(4):236-7. PubMed ID: 17308370
[No Abstract] [Full Text] [Related]
16. Description of a new BCR-ABL point mutation in a CML patient with evolution to lymphoid blast crisis.
Hokama PO; Capannacci J; Hokama NK; Cliquet MG; Souza MP; Mauad MA; Colturato VA
Leuk Res; 2010 Apr; 34(4):e106-7. PubMed ID: 19931180
[No Abstract] [Full Text] [Related]
17. Frequent p53 gene mutations in blast crisis of chronic myelogenous leukemia, especially in myeloid crisis harboring loss of a chromosome 17p.
Nakai H; Misawa S; Toguchida J; Yandell DW; Ishizaki K
Cancer Res; 1992 Dec; 52(23):6588-93. PubMed ID: 1423304
[TBL] [Abstract][Full Text] [Related]
18. Blast crisis in chronic myeloid leukaemia.
Parikh PM; Karandikar SM; Pahuja R; Saikia T; Gopal R; Advani SH
J Assoc Physicians India; 1988 Feb; 36(2):181-2. PubMed ID: 3182655
[No Abstract] [Full Text] [Related]
19. BCR and BCR-ABL regulation during myeloid differentiation in healthy donors and in chronic phase/blast crisis CML patients.
Marega M; Piazza RG; Pirola A; Redaelli S; Mogavero A; Iacobucci I; Meneghetti I; Parma M; Pogliani EM; Gambacorti-Passerini C
Leukemia; 2010 Aug; 24(8):1445-9. PubMed ID: 20520635
[TBL] [Abstract][Full Text] [Related]
20. Mutations of the myeloid transcription factor CEBPA are not associated with the blast crisis of chronic myeloid leukaemia.
Pabst T; Stillner E; Neuberg D; Nimer S; Willman CL; List AF; Melo JV; Tenen DG; Mueller BU
Br J Haematol; 2006 May; 133(4):400-2. PubMed ID: 16643447
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
